Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting
Experts from Roswell Park Comprehensive Cancer Center will share the findings of a novel approach using radiation therapy to treat lung cancer at the American Society for Radiation Oncology (ASTRO) Annual Meeting Sept. 27-Oct. 1, 2025, in San Francisco.
Clinical Scorecard: Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting
At a Glance
Category Detail
Condition Non-Small Cell Lung Cancer (NSCLC) Key Mechanisms Single-fraction stereotactic body radiation therapy post-surgery Target Population Patients with non-small cell lung cancer post-surgery Care Setting Oncology department at Roswell Park Comprehensive Cancer Center
Key Highlights
Presentation of a novel radiation therapy approach at ASTRO Annual Meeting Single-arm, prospective clinical trial evaluating post-operative radiation therapy Study led by Dr. Anurag Singh, focusing on feasibility and toxicity analysis Guideline-Based Recommendations
Diagnosis
Evaluate patients with non-small cell lung cancer for surgical intervention Management
Consider single-fraction stereotactic body radiation therapy post-surgery Monitoring & Follow-up
Assess for potential toxicity and treatment outcomes in post-operative patients Risks
Monitor for adverse effects associated with high-dose radiation therapy Patient & Prescribing Data
Post-operative non-small cell lung cancer patients
Single high dose of radiation may improve treatment outcomes
Clinical Best Practices
Implement early initiation of radiation therapy when appropriate Utilize a multidisciplinary approach in managing lung cancer patients Related Resources & Content
